In vivo susceptibility of the Legionnaires disease bacterium to ten antimicrobial agents.
The susceptibility of the Legionnaires disease bacterium to various antimicrobial agents was determined by inoculation of embryonated eggs via the yolk sac. When administered prophylactically, the minimal dose of drug preventing all deaths due to the infection was as follows: rifampin, 0.02 mg; gentamicin, 0.25 mg; streptomycin, 0.39 mg; erythromycin, 0.62 mg; sulfadiazine, 1.56 mg; chloramphenicol, 2.50 mg; and cephalothin, 20.0 mg. Smaller amounts delayed deaths, and larger or equal amounts rendered the embryos free of infection. Oxytetracycline in the largest tested amount, 5.0 mg, protected 80% of the embryos from death, and as little as 0.31 mg delayed death. Chlortetracycline (0.50 mg) and ampicillin (10.0 mg) were ineffective. The six most effective drugs were studied in an experiment in which they were administered at various times after infection in doses that were twice the minimal prophylactic dose preventing all deaths. In this therapeutic experiment, rifampin, and erythromycin allowed 100% survival when given even 72 h after infection; gentamicin, streptomycin, sulfadiazine, and chloramphenicol did so when given 48 h after infection. All six drugs increased mean survival time when administered 72 h after infection.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002642:Chick Embryo; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D007875:Legionella / Q000187:drug effects*; D007877:Legionnaires' Disease / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D012293:Rifampin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D004917:Erythromycin; D012293:Rifampin
J Bacteriol. 1950 Apr;59(4):509-22
15436424
Stain Technol. 1964 May;39:135-40
14157454
J Clin Microbiol. 1977 Aug;6(2):140-3
893658
N Engl J Med. 1977 Dec 1;297(22):1189-97
335244
N Engl J Med. 1977 Dec 1;297(22):1197-203
335245